Autobio Diagnostics
VC Fund
Zhengzhou, China
Autobio Diagnostics is a company mainly engaged in development, manufacture and sales of diagnostics products.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Autobio Diagnostics invests in
Stages Autobio Diagnostics invests in
Countries Autobio Diagnostics invests in
Investment Focus
Industry
- Medical Device 2 (50%)
- Medical 1 (25%)
- Industrial 1 (25%)
- Health Care 1 (25%)
- Life Science 1 (25%)
Stage
- Series A 2 (50%)
- Venture - Series Unknown 2 (50%)
Country
- China 3 (75%)
- Finland 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| SpaceGen is dedicated to providing innovative services for individualized precision medical testing of tumors. | Venture - Series Unknown / Dec 31, 2025 | ||
| Meili Technology has independently created commercial gene sequencing instruments and supporting reagents with ultra-long read length, no amplification, quick, accuracy, and low cost, with the goal of opening up the product closed loop from sample preparation to report generation. | Series A / Feb 15, 2023 | ||
| CORUI manufactures and develops chromatographic instruments. Its instruments offer high accuracy, high speed, and low-cost operations, enabling customers to cut costs and improve operational efficiency. | Series A / Jun 09, 2022 | ||
| Mobidiag is a commercial stage, fast-growing Finnish-French biotechnology company that develops and markets innovative molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management, healthcare associated infections (HAIs), respiratory infections and sepsis. Based on well-established qPCR and microarraytechnologies, Mobidiag offers a broad range of tests and automated platforms. These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and markers for antibiotic resistance. | $11.4M / Venture - Series Unknown / Dec 17, 2018 |
Co-Investors
Future Capital Discovery Fund
1 deal together
Topping Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Autobio Diagnostics invest in?
Autobio Diagnostics invests primarily in Medical Device, Medical and Industrial startups, most often at Series A and Venture - Series Unknown stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Autobio Diagnostics last invest?
The most recent investment recorded for Autobio Diagnostics closed in Dec 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
